Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease.

Kikuchi K, Saigusa D, Kanemitsu Y, Matsumoto Y, Thanai P, Suzuki N, Mise K, Yamaguchi H, Nakamura T, Asaji K, Mukawa C, Tsukamoto H, Sato T, Oikawa Y, Iwasaki T, Oe Y, Tsukimi T, Fukuda NN, Ho HJ, Nanto-Hara F, Ogura J, Saito R, Nagao S, Ohsaki Y, Shimada S, Suzuki T, Toyohara T, Mishima E, Shima H, Akiyama Y, Akiyama Y, Ichijo M, Matsuhashi T, Matsuo A, Ogata Y, Yang CC, Suzuki C, Breeggemann MC, Heymann J, Shimizu M, Ogawa S, Takahashi N, Suzuki T, Owada Y, Kure S, Mano N, Soga T, Wada T, Kopp JB, Fukuda S, Hozawa A, Yamamoto M, Ito S, Wada J, Tomioka Y, Abe T.

Nat Commun. 2019 Apr 23;10(1):1835. doi: 10.1038/s41467-019-09735-4.

2.

Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials.

Mishima E, Haruna Y, Arima H.

Hypertens Res. 2019 Apr;42(4):469-482. doi: 10.1038/s41440-018-0116-3. Epub 2019 Apr 5.

PMID:
30948820
3.

tiRNAs as a novel biomarker for cell damage assessment in in vitro ischemia-reperfusion model in rat neuronal PC12 cells.

Elkordy A, Rashad S, Shehabeldeen H, Mishima E, Niizuma K, Abe T, Tominaga T.

Brain Res. 2019 Jul 1;1714:8-17. doi: 10.1016/j.brainres.2019.02.019. Epub 2019 Feb 16.

PMID:
30779912
4.

Immuno-Northern Blotting: Detection of Modified RNA Using Gel Separation and Antibodies to Modified Nucleosides.

Mishima E, Abe T.

Methods Mol Biol. 2019;1870:179-187. doi: 10.1007/978-1-4939-8808-2_13.

PMID:
30539555
5.

Low frequency of cervicocranial artery involvement in Japanese with renal artery fibromuscular dysplasia compared with that of Caucasians.

Mishima E, Umezawa S, Suzuki T, Fujimura M, Abe M, Hashimoto J, Abe T, Ito S.

Clin Exp Nephrol. 2018 Dec;22(6):1294-1299. doi: 10.1007/s10157-018-1575-1. Epub 2018 Apr 20.

PMID:
29679353
6.

Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review.

Mishima E, Suzuki T, Takeuchi Y, Seiji K, Fukuhara N, Takase K, Harigae H, Abe T, Ito S.

J Clin Hypertens (Greenwich). 2018 Apr;20(4):798-804. doi: 10.1111/jch.13257. Epub 2018 Apr 14.

7.

Stress-induced tRNA cleavage and tiRNA generation in rat neuronal PC12 cells.

Elkordy A, Mishima E, Niizuma K, Akiyama Y, Fujimura M, Tominaga T, Abe T.

J Neurochem. 2018 Sep;146(5):560-569. doi: 10.1111/jnc.14321. Epub 2018 Apr 22.

PMID:
29431851
8.

Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.

Sato E, Saigusa D, Mishima E, Uchida T, Miura D, Morikawa-Ichinose T, Kisu K, Sekimoto A, Saito R, Oe Y, Matsumoto Y, Tomioka Y, Mori T, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Toxins (Basel). 2017 Dec 28;10(1). pii: E19. doi: 10.3390/toxins10010019.

9.

Focal Segmental Glomerulosclerosis Associated with Chronic Progressive External Ophthalmoplegia and Mitochondrial DNA A3243G Mutation.

Narumi K, Mishima E, Akiyama Y, Matsuhashi T, Nakamichi T, Kisu K, Nishiyama S, Ikenouchi H, Kikuchi A, Izumi R, Miyazaki M, Abe T, Sato H, Ito S.

Nephron. 2018;138(3):243-248. doi: 10.1159/000485109. Epub 2017 Nov 30.

PMID:
29190634
10.

Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.

Mishima E, Fukuda S, Kanemitsu Y, Saigusa D, Mukawa C, Asaji K, Matsumoto Y, Tsukamoto H, Tachikawa T, Tsukimi T, Fukuda NN, Ho HJ, Kikuchi K, Suzuki C, Nanto F, Suzuki T, Ito S, Soga T, Tomioka Y, Abe T.

Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F824-F833. doi: 10.1152/ajprenal.00314.2017. Epub 2017 Nov 22.

PMID:
29167170
11.

Inherited, not acquired, Gitelman syndrome in a patient with Sjögren's syndrome: importance of genetic testing to distinguish the two forms.

Mishima E, Mori T, Sohara E, Uchida S, Abe T, Ito S.

CEN Case Rep. 2017 Nov;6(2):180-184. doi: 10.1007/s13730-017-0271-4. Epub 2017 Aug 17.

12.

Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole.

Mishima E, Maruyama K, Nakazawa T, Abe T, Ito S.

Intern Med. 2017;56(13):1687-1690. doi: 10.2169/internalmedicine.56.8313. Epub 2017 Jul 1.

13.

Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases.

Matsuhashi T, Sato T, Kanno SI, Suzuki T, Matsuo A, Oba Y, Kikusato M, Ogasawara E, Kudo T, Suzuki K, Ohara O, Shimbo H, Nanto F, Yamaguchi H, Saigusa D, Mukaiyama Y, Watabe A, Kikuchi K, Shima H, Mishima E, Akiyama Y, Oikawa Y, Hsin-Jung HO, Akiyama Y, Suzuki C, Uematsu M, Ogata M, Kumagai N, Toyomizu M, Hozawa A, Mano N, Owada Y, Aiba S, Yanagisawa T, Tomioka Y, Kure S, Ito S, Nakada K, Hayashi KI, Osaka H, Abe T.

EBioMedicine. 2017 Jun;20:27-38. doi: 10.1016/j.ebiom.2017.05.016. Epub 2017 May 13.

14.

Selective embolization therapy for intrarenal artery stenosis causing renovascular hypertension: Efficacy and follow-up renal imaging.

Mishima E, Suzuki T, Seiji K, Akiyama Y, Ota H, Hashimoto J, Takase K, Abe T, Ito S.

J Clin Hypertens (Greenwich). 2017 Oct;19(10):1028-1031. doi: 10.1111/jch.13040. Epub 2017 May 30.

15.

Potential Drug Interactions Mediated by Renal Organic Anion Transporter OATP4C1.

Sato T, Mishima E, Mano N, Abe T, Yamaguchi H.

J Pharmacol Exp Ther. 2017 Aug;362(2):271-277. doi: 10.1124/jpet.117.241703. Epub 2017 May 26.

PMID:
28550055
16.

A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β1 pathways.

Shima H, Sasaki K, Suzuki T, Mukawa C, Obara T, Oba Y, Matsuo A, Kobayashi T, Mishima E, Watanabe S, Akiyama Y, Kikuchi K, Matsuhashi T, Oikawa Y, Nanto F, Akiyama Y, Ho HJ, Suzuki C, Saigusa D, Masamune A, Tomioka Y, Masaki T, Ito S, Hayashi KI, Abe T.

Sci Rep. 2017 May 15;7(1):1884. doi: 10.1038/s41598-017-01702-7.

17.

Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.

Mishima E, Fukuda S, Mukawa C, Yuri A, Kanemitsu Y, Matsumoto Y, Akiyama Y, Fukuda NN, Tsukamoto H, Asaji K, Shima H, Kikuchi K, Suzuki C, Suzuki T, Tomioka Y, Soga T, Ito S, Abe T.

Kidney Int. 2017 Sep;92(3):634-645. doi: 10.1016/j.kint.2017.02.011. Epub 2017 Apr 8.

18.

'Lead pipe'-like stiff aorta with grossly widened pulse pressure in burned-out Takayasu arteritis.

Mishima E, Suzuki T, Hashimoto J, Abe T, Ito S.

Eur Heart J Cardiovasc Imaging. 2017 Jul 1;18(7):819. doi: 10.1093/ehjci/jex047. No abstract available.

PMID:
28369232
19.

[Influence of microbiota on renal disease: The two faces of Janus].

Mishima E, Abe T.

Nihon Jinzo Gakkai Shi. 2017;59(4):557-561. Japanese. No abstract available.

PMID:
30620805
20.

Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.

Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N, Saigusa D, Miura D, Morikawa-Ichinose T, Saito R, Oba-Yabana I, Oe Y, Kisu K, Naganuma E, Koizumi K, Mokudai T, Niwano Y, Kudo T, Suzuki C, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Sci Rep. 2016 Nov 10;6:36618. doi: 10.1038/srep36618.

Supplemental Content

Loading ...
Support Center